Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

PURPOSE: To evaluate the efficacy and safety of low dosages of rituximab (RTX) in the treatment of MuSK-antibody-positive MG patients. PATIENTS AND METHODS: We retrospectively analyzed the data of MuSK-antibody-positive MG patients who were treated with low dosages of RTX from January 2018 to Octobe...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xin, Zeng, Ziling, Wang, Yunda, Guo, Shuai, Wang, Chunjuan, Wang, Baojie, Guo, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078430/
https://www.ncbi.nlm.nih.gov/pubmed/35535211
http://dx.doi.org/10.2147/NDT.S358851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078430/
https://www.ncbi.nlm.nih.gov/pubmed/35535211
http://dx.doi.org/10.2147/NDT.S358851

Ejemplares similares